Copeptin in critical illness

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 10, 2014, Pages 1391-1393

  Latronico, Nicola ^a   Alberto Castioni, Carlo ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; COPEPTIN; CORTICOTROPIN; GLUCAGON; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROPOFOL; SODIUM; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN; ARGIPRESSIN; GLYCOPEPTIDE;

ACUTE DISEASE; ACUTE HEART INFARCTION; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BREATHING RATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; CORRELATIONAL STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIURESIS; EDITORIAL; EMERGENCY WARD; EUTHYROID SICK SYNDROME; HUMAN; HYPERCORTISOLISM; HYPOXEMIA; INJURY SEVERITY; INTENSIVE CARE UNIT; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; THORAX PAIN; TISSUE INJURY; TISSUE OXYGENATION; TRAUMATIC BRAIN INJURY; VASOPRESSIN BLOOD LEVEL; VENTILATOR ASSOCIATED PNEUMONIA; BLOOD; DISEASES;

ARGININE VASOPRESSIN; DISEASE; GLYCOPEPTIDES; HUMANS;

EID: 84921414708     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0529     Document Type: Editorial

References (30)

1. Bolignano D, Cabassi A, Fiaccadori E, Ghigo E, Pasquali R, Peracino A, et al. Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med 2014;52:1447-56.
2. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004;364: 545-8.
3. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intens Care Med 2003;29:1417-25.
4. Russell JA. Vasopressin and its copilot copeptin in sepsis and septic shock. Crit Care Med 2009;37:749-50.
5. Katan M, Christ-Crain M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Med Weekly 2010;140:w13101.
6. Nickel CH, Bingisser R, Morgenthaler NG. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 2012;10:7.
7. Nickel CH, Messmer AS, Geigy N, Misch F, Mueller B, Dusemund F, et al. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning. Acad Emerg Med 2013;20:670-9.
8. Kruger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T. Cardiovascular and inflammatory biomarkers to predict shortand long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med 2010;182:1426-34.
9. Kolditz M, Halank M, Schulte-Hubbert B, Bergmann S, Albrecht S, Hoffken G. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med 2012;106:1320-8.
10. Boeck L, Eggimann P, Smyrnios N, Pargger H, Thakkar N, Siegemund M, et al. The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia. J Crit Care 2012;27:523,e521-9.
11. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ- Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007;28:219-26.
12. Jochberger S, Dorler J, Luckner G, Mayr VD, Wenzel V, Ulmer H, et al. The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med 2009;37:476-82.
13. Oliveira-Pelegrin GR, Basso PJ, Rocha MJ. Cellular bioenergetics changes in magnocellular neurons may affect copeptin expression in the late phase of sepsis. J Neuroimmunol 2014;267:28-34.
14. Lee JH, Chan YH, Lai OF, Puthucheary J. Vasopressin and copeptin levels in children with sepsis and septic shock. Intens Care Med 2013;39:747-53.
15. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009;66:799-808.
16. De Marchis GM, Katan M, Weck A, Fluri F, Foerch C, Findling O, et al. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. Neurology 2013;80:1278-86.
17. Zhu XD, Chen JS, Zhou F, Liu QC, Chen G, Zhang JM. Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Crit Care 2011;15:R288.
18. Fung C, De Marchis GM, Katan M, Seiler M, Arnold M, Gralla J, et al. Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. PloS One 2013;8:e53191.
19. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, et al. Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 2010;10:34.
20. Dong XQ, Huang M, Yang SB, Yu WH, Zhang ZY. Copeptin is associated with mortality in patients with traumatic brain injury. J Trauma 2011;71:1194-8.
21. Kleindienst A, Brabant G, Morgenthaler NG, Dixit KC, Parsch H, Buchfelder M. Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregu- lation but correlates with injury severity. Acta Neurochir Suppl 2010;106:221-4.
22. Lippi G, Plebani M, Di Somma S, Monzani V, Tubaro M, Volpe M, et al. Considerations for early acute myocardial infarction ruleout for emergency department chest pain patients: the case of copeptin. Clin Chem Lab Med 2012;50:243-53.
23. Sebbane M, Lefebvre S, Kuster N, Jreige R, Jacques E, Badiou S, et al. Early rule out of acute myocardial infarction in ED patients: value of combined high-sensitivity cardiac troponin T and ultrasensitive copeptin assays at admission. Am J Emerg Med 2013;31:1302-8.
24. Bahrmann P, Bahrmann A, Breithardt OA, Daniel WG, Christ M, Sieber CC, et al. Additional diagnostic and prognostic value of copeptin ultra-sensitive for diagnosis of non-ST-elevation myocardial infarction in older patients presenting to the emergency department. Clin Chem Lab Med 2013;51:1307-19.
25. Mockel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 2014. [Epub ahead of print 30 Apr 2014].
26. Duchenne J, Mestres S, Dublanchet N, Combaret N, Marceau G, Caumon L, et al. Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation. Br Med J Open 2014;4:e004449.
27. Vetrone F, Santarelli S, Russo V, Lalle I, De Berardinis B, Magrini L, et al. Copeptin decrease from admission to discharge has favorable prognostic value for 90-day events in patients admitted with dyspnea. Clin Chem Lab Med 2014;52:1457-64.
28. O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, et al. Prognostic performance of multiple biomarkers in patients with non-ST elevation acute coronary syndrome: analysis from MERLIN-TIMI 36. J Am College Cardiol 2014;63:1644-53.
29. Plebani M, Melichar B. Quo vadis, biomarkers? Clin Chem Lab Med 2014;52:761-4.
30. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408-16.